These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15629154)

  • 1. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2005 Feb; 327(2):589-96. PubMed ID: 15629154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-Eda M; Yabuta N; Yoshihashi K; Kitazawa T; Suzuki T; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Ono Y; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2005 Jan; 326(4):859-65. PubMed ID: 15607748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
    Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.
    Kohrt JT; Filipski KJ; Cody WL; Cai C; Dudley DA; Van Huis CA; Willardsen JA; Rapundalo ST; Saiya-Cork K; Leadley RJ; Narasimhan L; Zhang E; Whitlow M; Adler M; McLean K; Chou YL; McKnight C; Arnaiz DO; Shaw KJ; Light DR; Edmunds JJ
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4752-6. PubMed ID: 16125385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor.
    Kadono S; Sakamoto A; Kikuchi Y; Oh-eda M; Yabuta N; Koga T; Hattori K; Shiraishi T; Haramura M; Kodama H; Esaki T; Sato H; Watanabe Y; Itoh S; Ohta M; Kozono T
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1227-33. PubMed ID: 15504346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.
    Kohrt JT; Filipski KJ; Cody WL; Cai C; Dudley DA; Van Huis CA; Willardsen JA; Narasimhan LS; Zhang E; Rapundalo ST; Saiya-Cork K; Leadley RJ; Edmunds JJ
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1060-4. PubMed ID: 16289811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.
    Shiraishi T; Kadono S; Haramura M; Kodama H; Ono Y; Iikura H; Esaki T; Koga T; Hattori K; Watanabe Y; Sakamoto A; Yoshihashi K; Kitazawa T; Esaki K; Ohta M; Sato H; Kozono T
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4533-7. PubMed ID: 18674905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores.
    Kotian PL; Krishnan R; Rowland S; El-Kattan Y; Saini SK; Upshaw R; Bantia S; Arnold S; Babu YS; Chand P
    Bioorg Med Chem; 2009 Jun; 17(11):3934-58. PubMed ID: 19409795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide exosite inhibitors of factor VIIa as anticoagulants.
    Dennis MS; Eigenbrot C; Skelton NJ; Ultsch MH; Santell L; Dwyer MA; O'Connell MP; Lazarus RA
    Nature; 2000 Mar; 404(6777):465-70. PubMed ID: 10761907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
    Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ
    Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K; Persson E; Carlsson U; Svensson M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of peptidomimetic factor VIIa inhibitors.
    Shiraishi T; Kadono S; Haramura M; Kodama H; Ono Y; Iikura H; Esaki T; Koga T; Hattori K; Watanabe Y; Sakamoto A; Yoshihashi K; Kitazawa T; Esaki K; Ohta M; Sato H; Kozono T
    Chem Pharm Bull (Tokyo); 2010 Jan; 58(1):38-44. PubMed ID: 20045964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.
    Roberge M; Santell L; Dennis MS; Eigenbrot C; Dwyer MA; Lazarus RA
    Biochemistry; 2001 Aug; 40(32):9522-31. PubMed ID: 11583151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-assisted solution-phase library synthesis and crystal structure of alpha-ketothiazoles as tissue factor VIIa inhibitors.
    Parlow JJ; Dice TA; Lachance RM; Girard TJ; Stevens AM; Stegeman RA; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4043-9. PubMed ID: 12954057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
    Chen SW; Pellequer JL; Schved JF; Giansily-Blaizot M
    Thromb Haemost; 2002 Jul; 88(1):74-82. PubMed ID: 12152682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
    Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.
    Sagi K; Fujita K; Sugiki M; Takahashi M; Takehana S; Tashiro K; Kayahara T; Yamanashi M; Fukuda Y; Oono S; Okajima A; Iwata S; Shoji M; Sakurai K
    Bioorg Med Chem; 2005 Mar; 13(5):1487-96. PubMed ID: 15698764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E; Olsen OH
    FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.